The bill amends existing laws regarding the management of anaphylaxis medications in schools, specifically focusing on the use of epinephrine and epinephrine autoinjectors. It allows school districts and private schools to maintain a supply of these medications based on student enrollment. Licensed health professionals can prescribe epinephrine in the name of the school, and the bill clarifies that there are no changes to current practices for students with existing prescriptions. Additionally, it establishes protocols for school nurses and trained personnel to use school supplies of epinephrine in response to anaphylactic reactions, whether or not a student has a personal prescription on file.

The bill also introduces new provisions regarding liability for school employees administering epinephrine, ensuring they are not held responsible for injuries resulting from its use if they comply with established protocols. It mandates the development of anaphylactic policy guidelines by the office of the superintendent of public instruction, in consultation with health authorities, to include training for school personnel and procedures for managing allergic reactions. The bill emphasizes the importance of communication and risk reduction strategies related to anaphylaxis in schools.

Statutes affected:
Original Bill: 28A.210.383, 28A.210.380
Substitute Bill: 28A.210.383, 28A.210.380